Tevard Biosciences

Tevard Biosciences company information, Employees & Contact Information

Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases.
Looking for a particular Tevard Biosciences employee's phone or email?

Tevard Biosciences Questions

News

Tevard Biosciences Presents Data Showing Compelling Full-Length Protein Rescue with tRNA-based Treatment for Duchenne Muscular Dystrophy and Dilated Cardiomyopathy at the 2025 FEBS Special Meeting - BioSpace

Tevard Biosciences Presents Data Showing Compelling Full-Length Protein Rescue with tRNA-based Treatment for Duchenne Muscular Dystrophy and Dilated Cardiomyopathy at the 2025 FEBS Special Meeting BioSpace

Tevard Biosciences Names Dr. Elisabeth Gardiner Chief Scientific Officer to Lead Next Phase of tRNA-Based Therapies - Yahoo Finance

Tevard Biosciences Names Dr. Elisabeth Gardiner Chief Scientific Officer to Lead Next Phase of tRNA-Based Therapies Yahoo Finance

Early Data Show Potential of Tevard’s tRNA Therapy in Duchenne Muscular Dystrophy - BioPharm International

Early Data Show Potential of Tevard’s tRNA Therapy in Duchenne Muscular Dystrophy BioPharm International

Tevard to Present Data Demonstrating tRNA-based Therapy Rescued Full-Length Dystrophin and Motor Function in Duchenne Muscular Dystrophy Model - BioSpace

Tevard to Present Data Demonstrating tRNA-based Therapy Rescued Full-Length Dystrophin and Motor Function in Duchenne Muscular Dystrophy Model BioSpace

Tevard Biosciences to Move Corporate Headquarters to Lilly Gateway Labs in Boston's Seaport - PR Newswire

Tevard Biosciences to Move Corporate Headquarters to Lilly Gateway Labs in Boston's Seaport PR Newswire

Tevard’s tRNA therapies gain ground for genetic epilepsies - BioWorld MedTech

Tevard’s tRNA therapies gain ground for genetic epilepsies BioWorld MedTech

Tevard Reports Data on Suppressor tRNA Therapy Restoring Full-Length Dystrophin in Duchenne Muscular Dystrophy Model - BioSpace

Tevard Reports Data on Suppressor tRNA Therapy Restoring Full-Length Dystrophin in Duchenne Muscular Dystrophy Model BioSpace

SRF awards $230,000 grant to advance research on SYNGAP1-Related Disorders - News-Medical

SRF awards $230,000 grant to advance research on SYNGAP1-Related Disorders News-Medical

Will tRNA therapy be the next big thing in genetic disease treatment? - Labiotech.eu

Will tRNA therapy be the next big thing in genetic disease treatment? Labiotech.eu

Vertex tiptoes further into Duchenne research with Tevard deal - BioPharma Dive

Vertex tiptoes further into Duchenne research with Tevard deal BioPharma Dive

Exclusive: Vertex drops AAV gene therapy research, tRNA therapy partnership - Endpoints News

Exclusive: Vertex drops AAV gene therapy research, tRNA therapy partnership Endpoints News

Boston Globe: Eli Lilly opens $700 million research center on Fort Point spot where GE headquarters was once planned - Massachusetts Biotechnology Council

Boston Globe: Eli Lilly opens $700 million research center on Fort Point spot where GE headquarters was once planned Massachusetts Biotechnology Council

Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy - PR Newswire

Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy PR Newswire

Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech - Fierce Biotech

Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech Fierce Biotech

tRNA therapies could help restore proteins lost in translation - Chemical & Engineering News

tRNA therapies could help restore proteins lost in translation Chemical & Engineering News

Patient-Driven Innovation and an Investigational tRNA-based Gene Therapy - BioPharm International

Patient-Driven Innovation and an Investigational tRNA-based Gene Therapy BioPharm International

Pharma giants pull back on AAV research: what’s next for the gene therapy space? - Labiotech.eu

Pharma giants pull back on AAV research: what’s next for the gene therapy space? Labiotech.eu

Tevard and Vertex collaborate on tRNA-based therapies for patients with Duchenne muscular dystrophy - BioWorld MedTech

Tevard and Vertex collaborate on tRNA-based therapies for patients with Duchenne muscular dystrophy BioWorld MedTech

Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies - PR Newswire

Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies PR Newswire

Flagship startup Alltrna raises $109M for tRNA therapies that restore missing proteins - Endpoints News

Flagship startup Alltrna raises $109M for tRNA therapies that restore missing proteins Endpoints News

They got Pfizer’s ‘Golden Ticket.’ Did it live up to the hype? - statnews.com

They got Pfizer’s ‘Golden Ticket.’ Did it live up to the hype? statnews.com

Pathogens Unit commissioned at Rand Memorial Hospital - The Tribune 242

Pathogens Unit commissioned at Rand Memorial Hospital The Tribune 242

Top Tevard Biosciences Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant